Capecitabine
CAS 154361-50-9 27 FDA-DMF suppliersSmall Molecule
Overview
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of various cancers, most notably colorectal and breast cancer. It is a prodrug that is metabolized to 5-fluorouracil, a molecule that inhibits thymidylate synthase, thereby blocking DNA synthesis in rapidly dividing tumor cells.
API suppliers (26)
Suppliers of Capecitabine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Intas Pharmaceuticals Ltd.India2 active DMF
- DIVI'S LABOTATORIES LTD1 active DMF
- SCINOPHARM TAIWAN LTD1 active DMF
- SHILPA PHARMA LIFESCIENCES LTD1 active DMF
- TAPI NL BV1 active DMF
- PHARMAZELL INDIA PRIVATE LTD1 active DMF
- ARCHIMICA SPA1 active DMF
- DIVI'S LABOTATORIES LTD1 active DMF
- DIVI'S LABOTATORIES LTD1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- ARCH PHARMALABS LTD1 active DMF
- CTX LIFE SCIENCES PVT LTD1 active DMF
- SCINOPHARM TAIWAN LTD1 active DMF
- SHILPA PHARMA LIFESCIENCES LTD1 active DMF
- PHARMAZELL INDIA PRIVATE LTD1 active DMF
- ARCHIMICA SPA1 active DMF
- Cadila Healthcare LimitedIndia
- SIGNA SA DE CV
- Cipla USA, Inc.USA
- MAC CHEM PRODUCTS INDIA PVT LTD
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina
- Jiangsu Hengrui Medicine Co., Ltd.China
- Zhejiang Hisun Pharmaceutical Co., Ltd.China
- APOTEX PHARMACHEM INC
- MYLAN LABORATORIES LTD
Showing 25 of 26 suppliers — see the full list in the app.
Therapeutic areas
Oncology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.